特朗普签署行政令加速PTSD疗法研发：美迷幻药物板块迎来“结构性拐点”，盘前全线飙升！

智通财经04-20

4月20日，在美国总统特朗普签署了一项旨在加速研究并扩大对用于治疗创伤后应激障碍(PTSD)的海外物质的获取渠道的行政令后，迷幻药物相关股票在盘前全线飙升！其中，Compass Pathways、Atai Beckley涨超25%，Definium Therapeutics、GH Research、Cybin均出现大幅上涨。投行奥本海默分析师杰伊·奥尔森表示，特朗普的行政令“通过促进研究、简化监管...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

无话不说
04-20
无话不说
说说你对这篇新闻的看法...

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2628742200?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","is_english":false,"pubTime":"2026-04-20 19:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2628742200","market":"hk","top_or_hot":-1,"title":"特朗普签署行政令加速PTSD疗法研发：美迷幻药物板块迎来“结构性拐点”，盘前全线飙升！","media":"智通财经","content":"<div>\n<p>4月20日，在美国总统特朗普签署了一项旨在加速研究并扩大对用于治疗创伤后应激障碍(PTSD)的海外物质的获取渠道的行政令后，迷幻药物相关股票在盘前全线飙升！其中，Compass Pathways、Atai Beckley涨超25%，Definium Therapeutics、GH Research、Cybin均出现大幅上涨。投行奥本海默分析师杰伊·奥尔森表示，特朗普的行政令“通过促进研究、简化监管...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1430797.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>特朗普签署行政令加速PTSD疗法研发：美迷幻药物板块迎来“结构性拐点”，盘前全线飙升！</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n特朗普签署行政令加速PTSD疗法研发：美迷幻药物板块迎来“结构性拐点”，盘前全线飙升！\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-20 19:23 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1430797.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>4月20日，在美国总统特朗普签署了一项旨在加速研究并扩大对用于治疗创伤后应激障碍(PTSD)的海外物质的获取渠道的行政令后，迷幻药物相关股票在盘前全线飙升！其中，Compass Pathways、Atai Beckley涨超25%，Definium Therapeutics、GH Research、Cybin均出现大幅上涨。投行奥本海默分析师杰伊·奥尔森表示，特朗普的行政令“通过促进研究、简化监管...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1430797.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B64QTZ34.USD","symbol_name":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) ACC","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1430797.html","article_id":"2628742200","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2628742200","pubTimestamp":1776684215,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，在美国总统特朗普签署了一项旨在加速研究并扩大对用于治疗创伤后应激障碍的海外物质的获取渠道的行政令后，迷幻药物相关股票在盘前交易中上涨。投行奥本海默分析师杰伊·奥尔森表示，特朗普的行政令“通过促进研究、简化监管时间表和扩大患者获取渠道，代表了美国迷幻药物行业的一个结构性拐点，这强化了我们的积极展望”。报告指出，这是该领域取得的又一积极进展，利好 RBC 覆盖的迷幻药物公司：Definium Therapeutics、Compass Pathways 和 GH Research。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"IE00B64QTZ34.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) ACC","BK4127":"投资银行业与经纪业","LU0128525929.USD":"TEMPLETON GLOBAL \"A\" (USD) ACC","LU2065731478.USD":"ALLSPRING (LUX) WORLDWIDE FUND - SMALL CAP INNOVA \"I\" (USD) ACC","BK4139":"生物科技","GHRS":"GH Research PLC","BK4559":"巴菲特持仓","LU0310800379.SGD":"FTIF - Templeton Global A Acc SGD","CMPS":"COMPASS Pathways plc","BK4207":"综合性银行","HELP":"Cybin Inc","ATAI":"Atai Beckley Inc","LU1267930573.SGD":"TEMPLETON GLOBAL \"AA\" (SGD) ACC A","BK4007":"制药","IE00BLDYK493.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) INC","BK4009":"广告","BK4539":"次新股","LU0708994859.HKD":"TEMPLETON GLOBAL \"A\" (HKD) ACC","BK4161":"工业机械","LU0029864427.USD":"TEMPLETON GLOBAL \"A\" (USD) INC"},"translate_title":"Trump signed an executive order to accelerate the research and development of PTSD therapy: the psychedelic drug sector in the United States ushered in a \"structural inflection point\" and soared across the board before the market!","themeId":"88f7b346cf902c973ba59a5779bb445e","isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/e1969c11b21504405cba7a4fb781e81c","symbols_score_info":{"GHRS":2,"HELP":2,"ATAI":2,"CMPS":2},"content_text":"4月20日，在美国总统特朗普签署了一项旨在加速研究并扩大对用于治疗创伤后应激障碍(PTSD)的海外物质的获取渠道的行政令后，迷幻药物相关股票在盘前全线飙升！其中，Compass Pathways、Atai Beckley涨超25%，Definium Therapeutics、GH Research、Cybin均出现大幅上涨。投行奥本海默分析师杰伊·奥尔森表示，特朗普的行政令“通过促进研究、简化监管时间表和扩大患者获取渠道，代表了美国迷幻药物行业的一个结构性拐点，这强化了我们的积极展望”。奥尔森继续看好 Atai Beckley、Compass Pathways 和 Definium Therapeutics，认为它们具有“差异化优势”。杰富瑞分析师安德鲁·蔡指出，随着特朗普政府、美国卫生与公众服务部(HHS)、食品药品监督管理局(FDA)以及退伍军人事务部(VA)等多个行政部门达成一致，“在 2027 年至 2030 年潜在的获批落地之前，投资者的关注度应会显著提升。”报道补充道，“商业化之路现在可能会变得更快。”与此同时，加拿大皇家银行(RBC)分析师布莱恩·亚伯拉罕斯认为，该行政令“加速了迷幻药物作为下一波心理健康关键疗法的发展”。报告指出，这是该领域取得的又一积极进展，利好 RBC 覆盖的迷幻药物公司：$Definium Therapeutics(DFTX)$、Compass Pathways 和 GH Research。","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[{"id":555641598391408,"gmtCreate":1776687857013,"gmtModify":1776690172785,"author":{"id":"3488499131201661","authorId":"3488499131201661","name":"无话不说","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"wearingBadges":[],"authorIdStr":"3488499131201661","idStr":"3488499131201661"},"htmlText":"说说你对这篇新闻的看法...","listText":"说说你对这篇新闻的看法...","text":"说说你对这篇新闻的看法...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/555641598391408","repostId":2628742200,"repostType":2,"repost":{"id":"2628742200","kind":"news","pubTimestamp":1776684215,"share":"https://www.laohu8.com/m/news/2628742200?lang=zh_CN&edition=full","pubTime":"2026-04-20 19:23","market":"hk","language":"zh","title":"特朗普签署行政令加速PTSD疗法研发：美迷幻药物板块迎来“结构性拐点”，盘前全线飙升！","url":"https://stock-news.laohu8.com/highlight/detail?id=2628742200","media":"智通财经","summary":"智通财经APP获悉，在美国总统特朗普签署了一项旨在加速研究并扩大对用于治疗创伤后应激障碍的海外物质的获取渠道的行政令后，迷幻药物相关股票在盘前交易中上涨。投行奥本海默分析师杰伊·奥尔森表示，特朗普的行政令“通过促进研究、简化监管时间表和扩大患者获取渠道，代表了美国迷幻药物行业的一个结构性拐点，这强化了我们的积极展望”。报告指出，这是该领域取得的又一积极进展，利好 RBC 覆盖的迷幻药物公司：Definium Therapeutics、Compass Pathways 和 GH Research。","content":"<html><head></head><body><p>4月20日，在美国总统特朗普签署了一项旨在加速研究并扩大对用于治疗创伤后应激障碍(PTSD)的海外物质的获取渠道的行政令后，迷幻药物相关股票在盘前全线飙升！</p><p>其中，<a href=\"https://laohu8.com/S/CMPS\">Compass Pathways</a>、<a href=\"https://laohu8.com/S/ATAI\">Atai Beckley</a>涨超25%，<a href=\"https://laohu8.com/S/DFTX\">Definium Therapeutics</a>、<a href=\"https://laohu8.com/S/GHRS\">GH Research</a>、<a href=\"https://laohu8.com/S/HELP\">Cybin</a>均出现大幅上涨。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a4439b4c364e57902daf2e886765c149\" title=\"\" tg-width=\"382\" tg-height=\"293\"/></p><p>投行奥本海默分析师杰伊·奥尔森表示，特朗普的行政令“通过促进研究、简化监管时间表和扩大患者获取渠道，代表了美国迷幻药物行业的一个结构性拐点，这强化了我们的积极展望”。奥尔森继续看好 Atai Beckley、Compass Pathways 和 Definium <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>，认为它们具有“差异化优势”。</p><p><a href=\"https://laohu8.com/S/JEF\">杰富瑞</a>分析师安德鲁·蔡指出，随着特朗普政府、美国卫生与公众服务部(HHS)、食品药品监督管理局(FDA)以及退伍军人事务部(VA)等多个行政部门达成一致，“在 2027 年至 2030 年潜在的获批落地之前，投资者的关注度应会显著提升。”报道补充道，“商业化之路现在可能会变得更快。”</p><p>与此同时，<a href=\"https://laohu8.com/S/RY\">加拿大皇家银行</a>(RBC)分析师布莱恩·亚伯拉罕斯认为，该行政令“加速了迷幻药物作为下一波心理健康关键疗法的发展”。</p><p>报告指出，这是该领域取得的又一积极进展，利好 RBC 覆盖的迷幻药物公司：$Definium <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>(DFTX)$、Compass Pathways 和 GH Research。</p></body></html>","source":"stock_zhitongcaijing","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>特朗普签署行政令加速PTSD疗法研发：美迷幻药物板块迎来“结构性拐点”，盘前全线飙升！</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n特朗普签署行政令加速PTSD疗法研发：美迷幻药物板块迎来“结构性拐点”，盘前全线飙升！\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-20 19:23 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1430797.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>4月20日，在美国总统特朗普签署了一项旨在加速研究并扩大对用于治疗创伤后应激障碍(PTSD)的海外物质的获取渠道的行政令后，迷幻药物相关股票在盘前全线飙升！其中，Compass Pathways、Atai Beckley涨超25%，Definium Therapeutics、GH Research、Cybin均出现大幅上涨。投行奥本海默分析师杰伊·奥尔森表示，特朗普的行政令“通过促进研究、简化监管...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1430797.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","relate_stocks":{"IE00B64QTZ34.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) ACC","BK4127":"投资银行业与经纪业","LU0128525929.USD":"TEMPLETON GLOBAL \"A\" (USD) ACC","LU2065731478.USD":"ALLSPRING (LUX) WORLDWIDE FUND - SMALL CAP INNOVA \"I\" (USD) ACC","BK4139":"生物科技","GHRS":"GH Research PLC","BK4559":"巴菲特持仓","LU0310800379.SGD":"FTIF - Templeton Global A Acc SGD","CMPS":"COMPASS Pathways plc","BK4207":"综合性银行","HELP":"Cybin Inc","ATAI":"Atai Beckley Inc","LU1267930573.SGD":"TEMPLETON GLOBAL \"AA\" (SGD) ACC A","BK4007":"制药","IE00BLDYK493.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) INC","BK4009":"广告","BK4539":"次新股","LU0708994859.HKD":"TEMPLETON GLOBAL \"A\" (HKD) ACC","BK4161":"工业机械","LU0029864427.USD":"TEMPLETON GLOBAL \"A\" (USD) INC"},"source_url":"http://www.zhitongcaijing.com/content/detail/1430797.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2628742200","content_text":"4月20日，在美国总统特朗普签署了一项旨在加速研究并扩大对用于治疗创伤后应激障碍(PTSD)的海外物质的获取渠道的行政令后，迷幻药物相关股票在盘前全线飙升！其中，Compass Pathways、Atai Beckley涨超25%，Definium Therapeutics、GH Research、Cybin均出现大幅上涨。投行奥本海默分析师杰伊·奥尔森表示，特朗普的行政令“通过促进研究、简化监管时间表和扩大患者获取渠道，代表了美国迷幻药物行业的一个结构性拐点，这强化了我们的积极展望”。奥尔森继续看好 Atai Beckley、Compass Pathways 和 Definium Therapeutics，认为它们具有“差异化优势”。杰富瑞分析师安德鲁·蔡指出，随着特朗普政府、美国卫生与公众服务部(HHS)、食品药品监督管理局(FDA)以及退伍军人事务部(VA)等多个行政部门达成一致，“在 2027 年至 2030 年潜在的获批落地之前，投资者的关注度应会显著提升。”报道补充道，“商业化之路现在可能会变得更快。”与此同时，加拿大皇家银行(RBC)分析师布莱恩·亚伯拉罕斯认为，该行政令“加速了迷幻药物作为下一波心理健康关键疗法的发展”。报告指出，这是该领域取得的又一积极进展，利好 RBC 覆盖的迷幻药物公司：$Definium Therapeutics(DFTX)$、Compass Pathways 和 GH Research。","news_type":1,"symbols_score_info":{"GHRS":2,"HELP":2,"ATAI":2,"CMPS":2}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"isCommentEnd":true,"newsSizeData":{"likeSize":3,"commentSize":1,"repostSize":1,"favoriteSize":2,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2628742200","isCrawlerRequest":true}